Pharma Equity Group A/S Cl A Cash Flow Reinvestment Rate
Latest as of December 2022:
0.00x
Pharma Equity Group A/S Cl A cash flow reinvestment rate. Pharma Equity Group A/S Cl A (PEG) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting Dkr0.00 (capex Dkr0.00 ) from operating cash flow of Dkr4.24 Million. Explore Pharma Equity Group A/S Cl A cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Dkr0.00
Capex + Investments
Operating Cash Flow
Dkr4.24 Million
DKK
Capital Expenditures
Dkr0.00
DKK
Pharma Equity Group A/S Cl A Cash Flow Reinvestment Rate by Year (None–None)
Pharma Equity Group A/S Cl A cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Pharma Equity Group A/S Cl A. For the full cash flow conversion analysis, see Pharma Equity Group A/S Cl A (PEG) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (DKK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow